Arkolith/Insider Trading/INDP/Form 4

Meckler Jeffrey A

Chief Executive Officer, DirectorIndaptus Therapeutics, Inc. (INDP) · full profile →Form 4 · filed Apr 11, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
0 non-derivative · 6 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 10, 2025Disposed to issuer(D)5K$0.04$1900
Apr 10, 2025Disposed to issuer(D)4K$0.04$1500
Apr 10, 2025Disposed to issuer(D)813$0.04$330
Apr 10, 2025Disposed to issuer(D)2K$0.04$600
Apr 10, 2025Disposed to issuer(D)2K$0.04$630
Apr 10, 2025Disposed to issuer(D)1K$0.04$500

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001641172-25-003824) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Indaptus Therapeutics, Inc.

Build

Ask your agent about INDP insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001641172-25-003824"
Ask your agent
Use Arkolith to summarize insider buying and selling at Indaptus Therapeutics, Inc.
over the last 90 days and cite the filings.